agilon health officer buys 500,000 shares

Rhea-AI Filing Summary

agilon health, inc. Chief Markets Officer Benjamin Shaker reported an open-market purchase of 500,000 shares of common stock at a weighted average price of $0.6021 per share. After this transaction, he directly owns 1,367,674 shares, a figure that includes restricted stock units.

Insider Trade Summary

Net Buyer: 500,000 shares

Net Buy 1 txn

Insider Shaker Benjamin

Role Chief Markets Officer

Bought 500,000 shs ($301K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	500,000	$0.6021	$301K

Holdings After Transaction: Common Stock — 1,367,674 shares (Direct)

Footnotes (2)

1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.5671 to $0.6137, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
2. F2. Includes restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did agilon health (AGL) report for Benjamin Shaker?

Benjamin Shaker, Chief Markets Officer of agilon health, reported buying 500,000 common shares. The purchase was an open-market transaction at a weighted average price of $0.6021 per share, increasing his directly owned stake to 1,367,674 shares, including restricted stock units.

At what price did Benjamin Shaker buy agilon health (AGL) shares?

Benjamin Shaker purchased agilon health common stock at a weighted average price of $0.6021 per share. The Form 4 notes multiple trades executed between $0.5671 and $0.6137, with the insider undertaking to provide detailed trade-break information upon request.

How many agilon health (AGL) shares does Benjamin Shaker own after this Form 4?

Following the reported transaction, Benjamin Shaker directly owns 1,367,674 agilon health common shares. This total includes restricted stock units, as disclosed in the Form 4 footnotes, reflecting both previously held and newly purchased shares in his direct ownership.

What type of transaction was reported in the agilon health (AGL) Form 4?

The Form 4 reports an open-market purchase of common stock coded as a “P” transaction. This indicates Shaker bought 500,000 shares in market trades, rather than receiving them through option exercises, awards, or other non-market acquisition mechanisms.

What does the price range in Benjamin Shaker’s agilon health (AGL) filing mean?

The filing states that the reported $0.6021 price is a weighted average of multiple trades. Individual purchases occurred at prices between $0.5671 and $0.6137 per share, and Shaker has agreed to provide full trade-by-trade price details to interested parties upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 05:28 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shaker Benjamin

(Last) (First) (Middle)

C/O AGILON HEALTH, INC.

440 POLARIS PARKWAY, SUITE 550

(Street)

WESTERVILLE OH 43082

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Markets Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		P		500,000	A	$0.6021(1)	1,367,674(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.5671 to $0.6137, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

2. Includes restricted stock units.

Remarks:

	/s/ Mimi Yang, as Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.